Erin Bohula, MD, DPhil is an Associate Physician in Cardiovascular Medicine at Brigham and Women’s Hospital, an Instructor of Medicine at Harvard Medical School, and an Investigator at the TIMI Study Group. Dr. Bohula earned her Doctor of Philosophy (D.Phil.) in Molecular Biology from Oxford University on a Rhodes Scholarship and her medical degree (M.D.) from Harvard Medical School. She completed her internal medicine residency and fellowships in cardiovascular medicine and critical care medicine at Brigham and Women’s Hospital. She is board certified in internal medicine, cardiology, and critical care medicine. In her role as a TIMI Study Group Investigator, Dr. Bohula studies pharmacologic interventions for cardiometabolic diseases, such as hyperlipidemia, obesity and atherosclerotic cardiovascular disease. Her recent trial involvement includes IMPROVE-IT, FOURIER and CAMELLIA-TIMI 61. As a cardiac intensivist and researcher, she is interested in innovative therapies and devices for critically-ill cardiovascular patients and was involved in creating the Critical Care Cardiology Trials Network, a North American research collaborative of cardiology critical care units (CICU). In addition to her scientific and trial responsibilities, Dr. Bohula is an active member of the clinical staff at Brigham and Women’s hospital and attends in the CICU.
